Globhy
AllBusinessHealthMarketingTechnologyTravelUncategorized
Posted on 55 minutes agoEdited on 55 minutes ago

Share:

United States Molecular Imaging Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

United States Molecular Imaging Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

Oncology is an important application segment because molecular imaging supports cancer detection, staging, treatment planning, recurrence assessment, and monitoring of therapeutic responses. Cardiovascular and neurological applications also contribute significantly.

6. Which are the major companies operating in the United States molecular imaging market?

Major companies include GE HealthCare, Siemens Healthineers AG, Koninklijke Philips N.V., Shimadzu Corporation, United Imaging Healthcare, Bruker Corporation, FUJIFILM Holdings, and Cubresa Inc.

7. What are the major challenges facing the United States molecular imaging market?

High equipment costs, specialized infrastructure requirements, radiopharmaceutical supply chain limitations, workforce shortages, and reimbursement variability are major challenges affecting market expansion.

8. How is artificial intelligence influencing molecular imaging?

AI is supporting image reconstruction, segmentation, attenuation correction, quantitative analysis, image interpretation, and workflow optimization. These capabilities can improve imaging efficiency and support more consistent diagnostic assessments.

9. Why is theranostics important for molecular imaging market growth?

Theranostics connects diagnostic imaging with targeted treatment. Molecular imaging helps identify patients with specific biological targets, supporting treatment selection and monitoring for targeted radiopharmaceutical therapies.

10. Which US states are important markets for molecular imaging?

California, Texas, New York, and Florida are important regional markets, supported by advanced healthcare infrastructure, cancer centers, academic institutions, and growing demand for specialized diagnostic services.

Conclusion

The United States molecular imaging market is positioned for continued expansion as healthcare providers increasingly prioritize early diagnosis, precision medicine, and targeted treatment approaches. Advances in PET and SPECT technologies, AI-powered imaging software, and radiopharmaceutical development are improving diagnostic capabilities and expanding clinical applications. Although high equipment costs, supply chain complexities, and workforce limitations remain challenges, ongoing investments in healthcare infrastructure and theranostics are expected to create new opportunities. With the market projected to reach US$ 3.6 billion by 2034, molecular imaging will remain an important part of the evolving US healthcare and diagnostic imaging industry.

Share:

More in Business

View category
When Freight Costs Fall: How Lower Shipping Rates Accelerate Iron Ore Price Declines